Quanterix Appoints Ivana Magovčević-Liebisch, Ph.D., J.D., to Board of Directors
Slice of Healthcare Team
10/07/2024
Key Highlights
- Ivana Magovčević-Liebisch brings over 25 years of biopharma experience to Quanterix.
- Founder and CEO of Vigil Neuroscience, leading Alzheimer’s therapy development.
- Quanterix’s Simoa® technology at the forefront of blood-based neuro biomarkers.
Source: Business Wire
Notable Quotes
“ Ivana’s business acumen and leadership experience will be invaluable as Quanterix expands its existing biomarker partnerships with pharma and biotech. ”
Masoud Toloue, CEO at Quanterix
“ Joining Quanterix’s Board of Directors presents an exciting opportunity to contribute to continued innovation and advancement in the industry. ”
Ivana Magovčević-Liebisch, Ph.D., J.D., President and CEO at Vigil Neuroscience
